-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Johnson & Johnson, Raises Price Target to $320

Benzinga·09/02/2026 13:41:30
Listen to the news
UBS analyst Michael Yee maintains Johnson & Johnson (NYSE:JNJ) with a Buy and raises the price target from $280 to $320.